Richard A Anderson
Overview
Explore the profile of Richard A Anderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
495
Citations
13239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sassarini J, Skorupskaite K, McLean J, Lumsden M, Anderson R
Climacteric
. 2025 Mar;
:1-8.
PMID: 40085748
Objective: Kisspeptin/neurokinin/dynorphin (KNDy) signaling links reproductive and thermoregulatory systems, and improvements in menopausal flushing are reported with neurokinin 3 receptor (NK3R) antagonists. A rise in brainstem activity preceding a flush...
2.
Salian S, Daddangadi A, Predheepan D, Bhagat Amonkar D, Pandya R, Laxminarayana S, et al.
Sci Rep
. 2024 Dec;
14(1):31042.
PMID: 39730849
Cyclophosphamide (CY) exposure is known to affect the ovary and impair fertility. Clinically, treatment is generally given over multiple doses, but research models have generally used single doses. The relative...
3.
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, et al.
Hum Reprod Open
. 2024 Dec;
2024(4):hoae065.
PMID: 39660328
Study Question: How should premature/primary ovarian insufficiency (POI) be diagnosed and managed based on the best available evidence from published literature? Summary Answer: The current guideline provides 145 recommendations on...
4.
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, et al.
Fertil Steril
. 2024 Dec;
123(2):221-236.
PMID: 39652037
Study Question: How should premature/primary ovarian insufficiency (POI) be diagnosed and managed, based on the best available evidence from published literature? Summary Answer: The current guideline provides 145 recommendations on...
5.
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, et al.
Climacteric
. 2024 Dec;
27(6):510-520.
PMID: 39647506
Study Question: How should premature/primary ovarian insufficiency (POI) be diagnosed and managed, based on the best available evidence from published literature? Summary Answer: The current guideline provides 145 recommendations on...
6.
Gifford R, OLeary T, Knight R, Wardle S, Doig C, Anderson R, et al.
J Appl Physiol (1985)
. 2024 Nov;
138(1):13-21.
PMID: 39589823
Reproductive endocrine function adapts to psychological, environmental, and energy-associated stressors. Multistressor environments upregulate hypothalamic-pituitary-adrenal (HPA) axis, causing suppression of the hypothalamic-pituitary-gonadal (HPG) axis, but it is not known if this...
7.
Carrillo N, Awasthi P, Lee J, Wen T, Chen M, Sterling C, et al.
J Cell Signal
. 2024 Nov;
5(3):114-121.
PMID: 39582486
Phosphoinositide (PIP) signaling plays pivotal roles in myriad biological processes and is altered in many diseases including cancer. Canonical PIP signaling involves membrane-associated PIP lipid second messengers that modulate protein...
8.
Turan V, Bedoschi G, Lee D, Barbosa C, de Oliveira R, Sacinti K, et al.
Clin Breast Cancer
. 2024 Oct;
25(2):108-116.e1.
PMID: 39428290
Introduction: Breast cancer is the most common malignancy in women of reproductive age and chemotherapy protocols impair fertility, frequently necessitating fertility preservation (FP) referral. Embryo, oocyte, or ovarian tissue cryopreservation...
9.
10.
Adverse obstetric outcomes in female survivors of adolescentand young adult cancers - Authors' reply
Reulen R, Sunguc C, Winter D, Rudge G, Polanco A, Birchenall K, et al.
Lancet Oncol
. 2024 Oct;
25(10):e468.
PMID: 39362254
No abstract available.